Immunomedics Announces Promotion Agreement With Janssen for Erdafitinib in the U.S.

NEXT STORY
Global Cell Isolation Market Will Reach USD 15.16 Billion By 2025: Zion Market Research
PREV STORY
Receptor Holdings Adds Alex Casdin to Board of Directors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

MacroGenics to Participate in Three Investor Conferences in September

ROCKVILLE, MD, Aug. 30, 2017 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage ...

author_avatar
NASDAQ Market News

Syneos Health Consulting Releases 10th Annual Biopharmaceutical Dealmakers Survey – Predicts M&A Landscape to Continue Bull Run, While Buyers Begin to Become More Risk Averse

BOSTON, June 05, 2018 (GLOBE NEWSWIRE) -- The tenth annual Dealmakers’ Intentions Study from ...

author_avatar
NASDAQ Market News

Heat Biologics Closes Public Offering of 5,000,000 Shares of Common Stock

DURHAM, N.C., March 28, 2017 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (Nasdaq:HTBX), a ...

author_avatar
NASDAQ Market News